Venous thromboembolic disease: Clinical practice guidelines in Oncology™
Recognizing the increased risk of VTE in cancer patients is the first step in preventing the occurrence of VTE and promptly identifying the disease in cancer patients. The NCCN panel recommends VTE thromboprophylaxis for all hospitalized patients with cancer who do not have contraindications to such therapy, and the panel also emphasizes that an increased level of clinical suspicion of VTE should be maintained for cancer patients. Careful evaluation and follow-up of cancer patients in whom VTE is suspected and prompt treatment and follow-up for patients diagnosed with VTE is recommended after the cancer status of the patient and the risks and benefits of treatment are considered. © Journal of the National Comprehensive Cancer Network.
Additional Document Info
has global citation frequency